36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Benet 75 mg Tablets
Phase of Trial: Phase IV
Latest Information Update: 18 Jul 2019
Price : $35 *
At a glance
- Drugs Risedronic acid (Primary)
- Indications Osteoporosis; Vertebral fracture
- Focus Therapeutic Use
- Sponsors Takeda
- 10 May 2018 Status changed from active, no longer recruiting to completed.
- 28 Sep 2017 Planned End Date changed from 1 Apr 2018 to 30 Apr 2018.
- 28 Sep 2017 Planned primary completion date changed from 1 Apr 2018 to 30 Apr 2018.